ReviewJournal of gastrointestinal cancer2026

Optimal First-Line Immunotherapy for MSI-H/dMMR Metastatic Colorectal Cancer: Evidence, Gaps, and Clinical Decision-Making.

Tamotsu Sagawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.